March 18, 2020 / 8:27 AM / 12 days ago

BRIEF-Synairgen To Start Trial Of SNG01 In COVID-19

March 18 (Reuters) - Synairgen PLC:

* SYNAIRGEN TO START TRIAL OF SNG001 IN COVID-19

* GOT APPROVALS FROM MHRA AND HRA TO CONDUCT A TRIAL OF SNG001 (INHALED FORMULATION OF INTERFERON-BETA-1A) IN COVID-19 PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below